CN118922429A - 异常磷酸化和tau蛋白聚集的抑制剂 - Google Patents

异常磷酸化和tau蛋白聚集的抑制剂 Download PDF

Info

Publication number
CN118922429A
CN118922429A CN202280089714.7A CN202280089714A CN118922429A CN 118922429 A CN118922429 A CN 118922429A CN 202280089714 A CN202280089714 A CN 202280089714A CN 118922429 A CN118922429 A CN 118922429A
Authority
CN
China
Prior art keywords
tau
compound
amide
nmr
sulfonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280089714.7A
Other languages
English (en)
Chinese (zh)
Inventor
A·瓦多奇
D·帕皮加西亚
G·波西奥
S·尚特皮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Amiens Picardie Jules Verne
Centre National de la Recherche Scientifique
Université Paris-Est Créteil Val de Marne
Original Assignee
University Amiens Picardie Jules Verne
Centre National de la Recherche Scientifique
Université Paris-Est Créteil Val de Marne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Amiens Picardie Jules Verne, Centre National de la Recherche Scientifique, Université Paris-Est Créteil Val de Marne filed Critical University Amiens Picardie Jules Verne
Publication of CN118922429A publication Critical patent/CN118922429A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN202280089714.7A 2021-11-29 2022-11-29 异常磷酸化和tau蛋白聚集的抑制剂 Pending CN118922429A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306658.2 2021-11-29
EP21306658 2021-11-29
PCT/EP2022/083709 WO2023094699A1 (fr) 2021-11-29 2022-11-29 Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau

Publications (1)

Publication Number Publication Date
CN118922429A true CN118922429A (zh) 2024-11-08

Family

ID=78851140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280089714.7A Pending CN118922429A (zh) 2021-11-29 2022-11-29 异常磷酸化和tau蛋白聚集的抑制剂

Country Status (6)

Country Link
US (1) US20250034194A1 (cg-RX-API-DMAC10.html)
EP (1) EP4441064A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024543187A (cg-RX-API-DMAC10.html)
CN (1) CN118922429A (cg-RX-API-DMAC10.html)
CA (1) CA3240163A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023094699A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240409505A1 (en) * 2023-06-12 2024-12-12 The Procter & Gamble Company Gluconamide sulfate surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686603A (en) * 1995-05-04 1997-11-11 Lever Brothers Company, Division Of Conopco, Inc. Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture
WO2007115372A1 (en) * 2006-04-10 2007-10-18 Monash University A method of modulating beta-amyloid peptide production

Also Published As

Publication number Publication date
US20250034194A1 (en) 2025-01-30
CA3240163A1 (fr) 2023-06-01
WO2023094699A1 (fr) 2023-06-01
JP2024543187A (ja) 2024-11-19
EP4441064A1 (fr) 2024-10-09

Similar Documents

Publication Publication Date Title
EP3402801B1 (en) Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
JP7590185B2 (ja) Taireファミリーキナーゼインヒビターおよびそれらの使用
CN112020358A (zh) 诱导蛋白质选择性降解的小分子及其用途
KR20140091459A (ko) 항바이러스 치료용 2''-플루오로 치환된 카바-누클레오시드 유사체
TW202039426A (zh) 泛硫醇(Pantetheine)衍生物及其用途
JP2022523864A (ja) ニコチンアミドリボシドのリン誘導体を含む組成物及びニコチンアミドアデニンジヌクレオチドのモジュレーションのための方法
AU2017363313A1 (en) Inhibitors of interleukin-1 receptor-associated kinases and uses thereof
KR20180075630A (ko) [1,2,4]트리아졸로[1,5-a]피리미딘-7-일 화합물
TR201815961T4 (tr) Yeni sitostatik 7-deazapürin nükleozidleri.
BR112013001553A2 (pt) Métodos e compostos para tratar infecções por vírus paramyxoviridae
EP3356447A1 (en) Inhibitors of menaquinone biosynthesis
JP2013537225A (ja) 変異cftrタンパク質の修飾因子としての化合物及びcftrタンパク質異常に関連する病気の治療へのその使用
US20220249411A1 (en) Calixarene compounds and uses thereof
Hwang et al. Synthetic phytoceramides induce apoptosis with higher potency than ceramides
CN106892920A (zh) 苦豆碱衍生物、其制备方法及用途
TW201241005A (en) Methods for synthesizing molybdopterin precursor Z derivatives
JP2018504411A (ja) 感覚有毛細胞の死を防ぐまたは処置するための化合物と方法
WO2010142827A1 (es) Propiedades neuroprotectoras de 5'-metiltioadenosina
KR20140105598A (ko) [1,2,4]트리아졸로피리딘 및 포스포디에스테라제 억제제로서의 이의 용도
US20250034194A1 (en) Inhibitors of abnormal phosphorylation and tau protein aggregation
TW201022279A (en) Chemical compounds
TWI803858B (zh) 化合物及其醫藥用途
JP2008529998A (ja) トポイソメラーゼII触媒インヒビターとしての6−エーテル/チオエーテル−プリンおよび療法(therapy)におけるその用途
JP2025505975A (ja) ニコチネート及びニコチンアミドリボシドベースの化合物及びその誘導体
TW201922690A (zh) 環-amp反應元素結合蛋白的抑制劑

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination